Subscribe To
Twitter gave rise to elon musk's fame, and amplified his ideas
Elon Musk has lived large in the public imagination since the early days of his life as an entrepreneur— espousing big ideas for tac...
April 14, 2022, 12:57 pm
Japan's smfg, tepco, mitsubishi face activist climate votes at agms
Big Japanese firms including Sumitomo Mitsui Financial Group, Tokyo Electric Power (Tepco) and Mitsubishi Corp will face resolutions from activist sha...
April 12, 2022, 11:03 pm
Kghg takes novel approach in tackling decarbonization
Climate change remains an ever-present looming elephant in the room, and the Russia-Ukraine war highlights concerns around the ongoing energy crisis a...
March 25, 2022, 12:53 pm
H&m selling other fashion brands on its website to better compete
H&M is tackling the competition in fashion by selling external fashion brands on its central website i...
March 17, 2022, 12:12 pm
Brilliant earth had a sparkling holiday season. the stock is rising.
Earnings of the online jeweler beat estimates. Investors were further encouraged by its stronger-than-expected guidance for 2022....
March 16, 2022, 4:58 pm
Tronox holdings: tackling debt while proving its worth
The Chemicals Manufacturing industry is poised to continue growth experienced from 2021 well into the year....
February 25, 2022, 3:46 pm
Tronox holdings: tackling debt while proving its worth
The Chemicals Manufacturing industry is poised to continue growth experienced from 2021 well into the year....
February 25, 2022, 3:46 pm
Tronox holdings: tackling debt while proving its worth
The Chemicals Manufacturing industry is poised to continue growth experienced from 2021 well into the year....
February 25, 2022, 3:46 pm
Upstart: tackling the legacy lending industry by the horns
The artificial intelligence (AI) lending industry took off in FY2021 with Upstart Holdings, Inc. emerging as a prominent player....
February 18, 2022, 7:08 am
Upstart: tackling the legacy lending industry by the horns
The artificial intelligence (AI) lending industry took off in FY2021 with Upstart Holdings, Inc. emerging as a prominent player....
February 18, 2022, 7:08 am
Upstart: tackling the legacy lending industry by the horns
The artificial intelligence (AI) lending industry took off in FY2021 with Upstart Holdings, Inc. emerging as a prominent player....
February 18, 2022, 7:08 am
Upstart ceo says company is ‘at the forefront' of tackling ancient problem of lending through ai
The act of borrowing and lending traces its roots back to ancient Mesopotamia, but Upstart Holdings Inc. says it's bringing a new approach to the prac...
February 17, 2022, 2:52 pm
Upstart ceo says company is ‘at the forefront' of tackling ancient problem of lending through ai
The act of borrowing and lending traces its roots back to ancient Mesopotamia, but Upstart Holdings Inc. says it's bringing a new approach to the prac...
February 17, 2022, 2:52 pm
Upstart ceo says company is ‘at the forefront' of tackling ancient problem of lending through ai
The act of borrowing and lending traces its roots back to ancient Mesopotamia, but Upstart Holdings Inc. says it's bringing a new approach to the prac...
February 17, 2022, 2:52 pm
Can nio stock recover in 2022?
NIO has lost as much as 43% of its value this year, buckling under mounting pressure from ongoing suppl...
February 17, 2022, 12:52 pm
Can nio stock recover in 2022?
NIO has lost as much as 43% of its value this year, buckling under mounting pressure from ongoing suppl...
February 17, 2022, 12:52 pm
Can nio stock recover in 2022?
NIO has lost as much as 43% of its value this year, buckling under mounting pressure from ongoing suppl...
February 17, 2022, 12:52 pm
Global blood therapeutics' oxbryta scores european approval for sickle cell disease
The European Commission (EC) has approved Global Blood Therapeutics Inc's (NASDAQ: GBT) Oxbryta (voxelotor) for hemolytic anemia due to sickle cell...
February 16, 2022, 9:41 am
Global blood therapeutics' oxbryta scores european approval for sickle cell disease
The European Commission (EC) has approved Global Blood Therapeutics Inc's (NASDAQ: GBT) Oxbryta (voxelotor) for hemolytic anemia due to sickle cell...
February 16, 2022, 9:41 am
Global blood therapeutics' oxbryta scores european approval for sickle cell disease
The European Commission (EC) has approved Global Blood Therapeutics Inc's (NASDAQ: GBT) Oxbryta (voxelotor) for hemolytic anemia due to sickle cell...
February 16, 2022, 9:41 am